SS-31 for Stimulant Load: Mitochondrial Support in a Multi-Peptide Stack
What's breaking down if you have Stimulant load (Adderall / amphetamine)
- Amphetamines force dopamine and norepinephrine release — borrow focus now.
- Sleep, appetite, and gut lining often suffer — less regeneration window.
- Chronic load can deplete neurochemistry and stress the gut-brain axis.
Layers:
- Dopamine system: Forced release → depletion → crash, anhedonia, tolerance.
- Sleep: Stimulants delay sleep onset and cut deep sleep.
- Gut: Stimulants stress mucosa; gut inflammation affects mood and cognition.
- Anxiety: Arousal without calm → jitter, rumination, non-restorative stress.
Why Semax might help you
- You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
- What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.
- What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.
- Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.
Why Selank might help you
- You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
- Layer breaking down: Anxiety — Arousal without calm → jitter, rumination, non-restorative stress.
- What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
- Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.
Why DSIP might help you
- You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
- Layer breaking down: Sleep — Stimulants delay sleep onset and cut deep sleep.
- What DSIP is studied to do: Studied for sleep architecture and deep-sleep promotion.
- Therefore for you: If that layer is part of your problem, DSIP is discussed because it targets repair (sleep / repair window) — not because it masks pain.
Why SS-31 (Elamipretide) might help you
- You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
- Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.
Why Amphetamine stimulants matters for you
- Drug: Amphetamine stimulants
- What it does: Forces neurotransmitter release; borrows focus at cost of sleep/gut reserve.
- Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.
How these fit together
Neural support (Semax), non-benzo calm (Selank), sleep repair window (DSIP) — each targets a stimulant-degeneration layer.
- Semax → neural / cognitive
- Selank → anxiety / neurochemistry
- DSIP → sleep / repair window
- SS-31 (Elamipretide) → mitochondrial
What the evidence actually shows
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 4
- Claims tagged human evidence: 2
- Claims tagged preclinical (animal/lab): 3
- Claims tagged anecdotal: 0
- Reddit posts catalogued: 0
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 5
Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.
Quantified confidence (this ledger): 0.46 / 1.00 — low–moderate — mostly preclinical
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice (source s1)
Mouse study showing mitochondrial protection against inflammation-induced dysfunction.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome (source s2)
Review proposing Semax for ADHD based on rodent dopamine and BDNF data.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety (source s3)
Rodent and clinical context for Selank anxiolytic action without typical benzo drawbacks.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
DSIP reduces amphetamine-induced hyperthermia in mice (source s4)
1984 mouse study on DSIP and amphetamine thermoregulation.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Peptide components (collapsible embeds)
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Evidence ledger 5 · tier-ranked · API
Model review1 contributions · 1 modelExpand the recursive review layer
/api/articles/ss-31-stimulants/contributionsAsk this article · 7 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.